Table S3.8 Prevalence of antimicrobial use and infection in residential aged care facilities, by jurisdiction, remoteness and provider type, 2015
Measure
|
Category
|
Number of facilities
|
Number of beds audited
|
Prevalence of antimicrobial use, n (%)
|
Prevalence of infection, n (%)
|
State
|
New South Wales
|
17
|
545
|
66 (12.1)
|
32 (5.9)
|
State
|
Queensland
|
7
|
481
|
31 (6.4)
|
17 (3.5)
|
State
|
South Australia
|
8
|
559
|
99 (17.7)
|
53 (9.5)
|
State
|
Tasmania
|
6
|
147
|
19 (12.9)
|
9 (6.1)
|
State
|
Victoria
|
130
|
4704
|
334 (7.1)
|
172 (3.7)
|
State
|
Western Australia
|
18
|
1153
|
310 (26.9)
|
61 (5.3)
|
Remoteness
|
Major cities
|
51
|
2881
|
397 (13.8)
|
127 (4.4)
|
Remoteness
|
Inner regional
|
81
|
3323
|
312 (9.4)
|
148 (4.5)
|
Remoteness
|
Outer regional
|
45
|
1245
|
123 (9.9)
|
50 (4.0)
|
Remoteness
|
Remote
|
8
|
128
|
25 (20.0)
|
17 (13.6)
|
Remoteness
|
Very remote
|
1
|
12
|
2 (16.7)
|
2 (16.7)
|
Provider type
|
Not for profit
|
37
|
2181
|
426 (19.5)
|
120 (5.5)
|
Provider type
|
Government
|
141
|
4963
|
395 (8.0)
|
207 (4.2)
|
Provider type
|
Private
|
8
|
445
|
38 (8.5)
|
17 (3.8)
|
National aggregate
|
na
|
186
|
7589
|
859 (11.3)
|
344 (4.5)
|
na = not applicable
Source: acNAPS, 2015
Table S3.9 World Health Organization defined daily doses for antibacterial agents included in the National Antimicrobial Utilisation Surveillance Program annual report Table S3.9a J01A Tetracyclines
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01AA Tetracyclines
|
J01AA02
|
Doxycycline
|
0.1
|
O, P
|
J01AA Tetracyclines
|
J01AA08
|
Minocycline
|
0.2
|
O, P
|
J01AA Tetracyclines
|
J01AA12
|
Tigecycline
|
0.1
|
P
|
ATC = Anatomical Therapeutic Chemical; O = oral; P = parenteral
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9b J01B Amphenicols
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01BA Amphenicols
|
J01BA01
|
Chloramphenicol
|
3
|
O, P
|
ATC = Anatomical Therapeutic Chemical; O = oral; P = parenteral
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9c J01C β-lactam antibacterials, penicillins
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01CA Penicillins with extended spectrum
|
J01CA01
|
Ampicillina
|
2
|
O, P
|
J01CA Penicillins with extended spectrum
|
J01CA04
|
Amoxicillina
|
1
|
O, P
|
J01CE β-lactamase-sensitive penicillins
|
J01CE01
|
Benzylpenicillina
|
3.6
|
P
|
J01CE β-lactamase-sensitive penicillins
|
J01CE02
|
Phenoxymethylpenicillina
|
2
|
O
|
J01CE β-lactamase-sensitive penicillins
|
J01CE08
|
Benzathine benzylpenicillina
|
3.6
|
P
|
J01CE β-lactamase-sensitive penicillins
|
J01CE09
|
Procaine penicillina
|
0.6
|
P
|
J01CF β-lactamase-resistant penicillins
|
J01CF01
|
Dicloxacillin
|
2
|
O, P
|
J01CF β-lactamase-resistant penicillins
|
J01CF05
|
Flucloxacillin
|
2
|
O, P
|
J01CR Combinations of penicillins, including β-lactamase inhibitors
|
J01CR02
|
Amoxycillin and enzyme inhibitora
|
1
|
O
|
J01CR Combinations of penicillins, including β-lactamase inhibitors
|
J01CR03
|
Ticarcillin and enzyme inhibitorb
|
15
|
P
|
J01CR Combinations of penicillins, including β-lactamase inhibitors
|
J01CR05
|
Piperacillin and enzyme inhibitorb
|
14
|
P
|
ATC = Anatomical Therapeutic Chemical; O = oral; P = parenteral
a Without antipseudomonal activity
b With antipseudomonal activity
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9d J01D Other β-lactam antibacterials
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01DB First-generation cephalosporins
|
J01DB01
|
Cefalexin
|
2
|
O
|
J01DB First-generation cephalosporins
|
J01DB03
|
Cefalotin
|
4
|
P
|
J01DB First-generation cephalosporins
|
J01DB04
|
Cefazolin
|
3
|
P
|
J01DC Second-generation cephalosporins
|
J01DC01
|
Cefoxitin
|
6
|
P
|
J01DC Second-generation cephalosporins
|
J01DC02
|
Cefuroxime
|
0.5
|
O
|
J01DC Second-generation cephalosporins
|
J01DC04
|
Cefaclor
|
1
|
O
|
J01DD Third-generation cephalosporins
|
J01DD01
|
Cefotaxime
|
4
|
P
|
J01DD Third-generation cephalosporins
|
J01DD02
|
Ceftazidime
|
4
|
P
|
J01DD Third-generation cephalosporins
|
J01DD04
|
Ceftriaxone
|
2
|
P
|
J01DE Fourth-generation cephalosporins
|
J01DE01
|
Cefepime
|
2
|
P
|
J01DH Carbapenems
|
J01DH02
|
Meropenem
|
2
|
P
|
J01DH Carbapenems
|
J01DH51
|
Imipenem and enzyme inhibitor
|
2
|
P
|
J01DH Carbapenems
|
J01DH03
|
Ertapenem
|
1
|
P
|
J01DH Carbapenems
|
J01DH04
|
Doripenem
|
1.5
|
P
|
J01DF Monobactams
|
J01DF01
|
Aztreonam
|
4
|
P
|
J01DI Other cephalosporins
|
J01DI02
|
Ceftaroline
|
1.2
|
P
|
ATC = Anatomical Therapeutic Chemical; O = oral; P = parenteral
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9e J01E Sulfonamides and trimethoprim
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01EA Trimethoprim and derivatives
|
J01EA01
|
Trimethoprim
|
0.4
|
O, P
|
J01EE Sulfonamides and trimethoprim
|
J01EE01
|
Sulfamethoxazole and trimethoprim
|
1.92
|
O, P
|
ATC = Anatomical Therapeutic Chemical; O = oral; P = parenteral
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9f J01F Macrolides, lincosamides and streptogramins
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01FA Macrolides
|
J01FA01
|
Erythromycin
|
1
|
O, P
|
J01FA Macrolides
|
J01FA01
|
Erythromycin ethylsuccinate
|
2
|
O
|
J01FA Macrolides
|
J01FA06
|
Roxithromycin
|
0.3
|
O
|
J01FA Macrolides
|
J01FA09
|
Clarithromycin
|
0.5
|
O
|
J01FA Macrolides
|
J01FA10
|
Azithromycin
|
0.3
|
O
|
J01FA Macrolides
|
J01FA10
|
Azithromycin
|
0.5
|
P
|
J01FF Lincosamides
|
J01FF01
|
Clindamycin
|
1.2
|
O
|
J01FF Lincosamides
|
J01FF01
|
Clindamycin
|
1.8
|
P
|
J01FF Lincosamides
|
J01FF02
|
Lincomycin
|
1.8
|
O, P
|
J01FG Streptogramins
|
J01FG01
|
Pristinamycin
|
2
|
O
|
J01FG Streptogramins
|
J01FG02
|
Quinupristin/dalfopristin
|
1.5
|
P
|
ATC = Anatomical Therapeutic Chemical; O = oral; P = parenteral
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9g J01G Aminoglycoside antibacterials
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01GB Other aminoglycosides
|
J01GB01
|
Tobramycin
|
0.24
|
P
|
J01GB Other aminoglycosides
|
J01GB01
|
Tobramycin
|
0.3
|
Inh solution
|
J01GB Other aminoglycosides
|
J01GB01
|
Tobramycin
|
0.112
|
Inh powder
|
J01GB Other aminoglycosides
|
J01GB03
|
Gentamicin
|
0.24
|
P
|
J01GB Other aminoglycosides
|
J01GB05
|
Neomycin
|
1
|
O
|
J01GB Other aminoglycosides
|
J01GB06
|
Amikacin
|
1
|
P
|
ATC = Anatomical Therapeutic Chemical; Inh = inhalation; O = oral; P = parenteral
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9h J01M Quinolone antibacterials
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01MA Fluoroquinolones
|
J01MA01
|
Ofloxacin (oral product not marketed in Australia but available through Special Access Scheme)
|
0.4
|
O
|
J01MA Fluoroquinolones
|
J01MA02
|
Ciprofloxacin
|
1
|
O
|
J01MA Fluoroquinolones
|
J01MA02
|
Ciprofloxacin
|
0.5
|
P
|
J01MA Fluoroquinolones
|
J01MA06
|
Norfloxacin
|
0.8
|
O
|
J01MA Fluoroquinolones
|
J01MA14
|
Moxifloxacin
|
0.4
|
O, P
|
ATC = Anatomical Therapeutic Chemical; O = oral; P = parenteral
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Table S3.9i J01X Other antibacterials
ATC code – chemical subgroup
|
ATC code
|
Generic name
|
Defined daily dose (grams)
|
Route
|
J01XA Glycopeptide antibacterials
|
J01XA01
|
Vancomycin
|
2
|
O, P
|
J01XA Glycopeptide antibacterials
|
J01XA02
|
Teicoplanin
|
0.4
|
P
|
J01XB Polymyxins
|
J01XB01
|
Colistin
|
3 MU
|
P, Inh
|
J01XC Steroid antibacterials
|
J01XC01
|
Fusidic acid
|
1.5
|
O, P
|
J01XD Imidazole derivatives
|
J01XD01
|
Metronidazole
|
1.5
|
P
|
J01XD Imidazole derivatives
|
J01XD01
|
Metronidazole
|
2
|
O, R
|
J01XD Imidazole derivatives
|
J01XD02
|
Tinidazole
|
2
|
O
|
J01XX Other antibacterials
|
J01XX08
|
Linezolid
|
1.2
|
O, P
|
J01XX Other antibacterials
|
J01XX09
|
Daptomycin
|
0.28
|
P
|
J04AB Antibiotics
|
J04AB02
|
Rifampicin
|
0.6
|
O, P
|
ATC = Anatomical Therapeutic Chemical; Inh = inhalation; MU = million units; O = oral; P = parenteral; R = rectal
Source: World Health Organization Collaborating Centre for Drug Statistics Methodology
Dostları ilə paylaş: |
